Everest Medicines Limited (HKG:1952)
Hong Kong · Delayed Price · Currency is HKD 70.60
+0.10 (0.14%)
Aug 15, 2025, 4:08 PM HKT
Everest Medicines Market Cap
Everest Medicines has a market cap or net worth of 24.77 billion as of August 15, 2025. Its market cap has increased by 309.03% in one year.
Market Cap
24.77B
Enterprise Value
23.68B
Revenue
752.03M
Ranking
n/a
PE Ratio
n/a
Stock Price
70.60
Market Cap Chart
Since October 9, 2020, Everest Medicines's market cap has increased from 20.64B to 24.77B, an increase of 20.04%. That is a compound annual growth rate of 3.84%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Aug 15, 2025 | 24.77B | 58.89% |
| Dec 31, 2024 | 15.59B | 132.87% |
| Dec 29, 2023 | 6.70B | 24.60% |
| Dec 30, 2022 | 5.37B | -47.96% |
| Dec 31, 2021 | 10.33B | -47.98% |
| Dec 31, 2020 | 19.85B | -3.81% |
| Oct 9, 2020 | 20.64B | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| BeOne Medicines | 265.60B |
| Hansoh Pharmaceutical Group Company | 226.30B |
| JD Health International | 179.05B |
| Innovent Biologics | 162.71B |
| Akeso | 141.46B |
| Sino Biopharmaceutical | 137.89B |
| WuXi Biologics | 125.37B |
| CSPC Pharmaceutical Group | 122.56B |